Leadership Team
Tillman U. Gerngross, PhD
Co-Founder and Chief Executive Officer- Co-Founder and CSO, GlycoFi Inc. (acquired by Merck 2006)
- Co-Founder, Chairman of Arsanis Inc. (merged with NASDAQ:XFOR in 2019)
- Co-Founder, Chairman of Avitide
- Co-Founder, Chairman of Alector (NASDAQ: ALEC)
- Professor of Bioengineering, Dartmouth College
- Venture Partner, SV Life Sciences
K. Dane Wittrup, PhD
Co-Founder and Chairman of the SAB- Co-Founder, BioDisplay Technologies (acquired by Abbott Laboratories 2001)
- Professor of Chemical Engineering and Bioengineering, Massachusetts Institute of Technology
- Co-Founder of Eleven Biotherapeutics
Eric Krauland, PhD
Chief Scientific Officer
Philip Chase
General Counsel- General Counsel, Alnylam Pharmaceuticals Inc.
- General Counsel, Epix Pharmaceuticals Inc.
- Chief Corporate Counsel, Transkaryotic Therapies Inc. (TKT)
Guy Van Meter
Chief Business Officer- Business Development and Strategic Alliances, Pfizer Inc.
- Business Development, Technology Licensing, Dyax Corp.
- F.W. Olin Graduate School of Management at Babson
Max Vásquez, PhD
Site Head, Adimab Palo Alto and Senior Vice President, Computational Biology- Senior Director, Research, PDL BioPharma
- Bocaraca Consulting, Founder and President
Ryan McGovern
Chief Financial Officer
Mary Schiavoni
Vice President, Human Resources- Program Management, Tuck School of Business at Dartmouth
- Human Resources, Bain & Company
- Business Development and Sales, TD Bank Group